IN2013MN02407A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MN02407A IN2013MN02407A IN2407MUN2013A IN2013MN02407A IN 2013MN02407 A IN2013MN02407 A IN 2013MN02407A IN 2407MUN2013 A IN2407MUN2013 A IN 2407MUN2013A IN 2013MN02407 A IN2013MN02407 A IN 2013MN02407A
- Authority
- IN
- India
- Prior art keywords
- compound
- formula
- salt
- paliperidone
- iii
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2407MUN2013 IN2013MN02407A (ru) | 2011-05-30 | 2012-05-30 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1592MU2011 | 2011-05-30 | ||
PCT/GB2012/000480 WO2012164242A1 (en) | 2011-05-30 | 2012-05-30 | Process for the preparation of paliperidone |
IN2407MUN2013 IN2013MN02407A (ru) | 2011-05-30 | 2012-05-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MN02407A true IN2013MN02407A (ru) | 2015-06-12 |
Family
ID=46201755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2407MUN2013 IN2013MN02407A (ru) | 2011-05-30 | 2012-05-30 |
Country Status (9)
Country | Link |
---|---|
US (1) | US9062049B2 (ru) |
EP (1) | EP2714687B1 (ru) |
JP (1) | JP2014515392A (ru) |
KR (1) | KR20140040766A (ru) |
AU (1) | AU2012264476B2 (ru) |
CA (1) | CA2837251A1 (ru) |
IN (1) | IN2013MN02407A (ru) |
WO (1) | WO2012164242A1 (ru) |
ZA (1) | ZA201309713B (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2012264476B2 (en) | 2011-05-30 | 2016-12-08 | Cipla Limited | Process for the preparation of paliperidone |
CN104292226B (zh) * | 2013-07-16 | 2016-12-28 | 江苏恩华药业股份有限公司 | 帕利哌酮氨基酸类衍生物及其应用 |
CN105481856B (zh) * | 2015-12-17 | 2017-07-28 | 合肥立方制药股份有限公司 | 一种帕利哌酮的制备方法 |
CN108250195A (zh) * | 2016-12-29 | 2018-07-06 | 江苏豪森药业集团有限公司 | 帕利哌酮的新合成方法 |
CN115109056A (zh) * | 2022-06-16 | 2022-09-27 | 常州市第四制药厂有限公司 | 一种帕利哌酮的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5158952A (en) | 1988-11-07 | 1992-10-27 | Janssen Pharmaceutica N.V. | 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use |
US7915412B2 (en) * | 2006-08-14 | 2011-03-29 | Teva Pharmaceutical Industries, Ltd. | Process for the synthesis of 9-hydroxy risperidone (paliperidone) |
JP2008546851A (ja) * | 2006-08-14 | 2008-12-25 | テバ ファーマシューティカル インダストリーズ リミティド | 純粋なパリペリドンとその製造法 |
US20080171876A1 (en) | 2007-05-10 | 2008-07-17 | Santiago Ini | Pure paliperidone and processes for preparing thereof |
EP2280967A2 (en) * | 2008-03-27 | 2011-02-09 | Actavis Group PTC EHF | Highly pure paliperidone or a pharmaceutically acceptable salt thereof substantially free of keto impurity |
ES2625323T3 (es) * | 2008-05-29 | 2017-07-19 | Inke, S.A. | Proceso para preparar paliperidona e intermedios de la misma |
US8481729B2 (en) | 2008-06-16 | 2013-07-09 | Msn Laboratories Limited | Processes for the preparation of paliperidone |
US20100010218A1 (en) | 2008-07-11 | 2010-01-14 | Jiri Bartl | Synthesis of paliperidone |
WO2010003703A2 (en) | 2008-07-11 | 2010-01-14 | Synthon B.V. | Paliperidone ketone |
ATE544766T1 (de) | 2009-07-13 | 2012-02-15 | Krka | Verfahren zur synthese von paliperidon |
AU2012264476B2 (en) | 2011-05-30 | 2016-12-08 | Cipla Limited | Process for the preparation of paliperidone |
-
2012
- 2012-05-30 AU AU2012264476A patent/AU2012264476B2/en not_active Ceased
- 2012-05-30 JP JP2014513240A patent/JP2014515392A/ja active Pending
- 2012-05-30 KR KR1020137034521A patent/KR20140040766A/ko not_active Application Discontinuation
- 2012-05-30 IN IN2407MUN2013 patent/IN2013MN02407A/en unknown
- 2012-05-30 CA CA2837251A patent/CA2837251A1/en not_active Abandoned
- 2012-05-30 WO PCT/GB2012/000480 patent/WO2012164242A1/en active Application Filing
- 2012-05-30 EP EP12725133.8A patent/EP2714687B1/en not_active Not-in-force
- 2012-05-30 US US14/122,108 patent/US9062049B2/en not_active Expired - Fee Related
-
2013
- 2013-12-20 ZA ZA2013/09713A patent/ZA201309713B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201309713B (en) | 2014-11-26 |
WO2012164242A8 (en) | 2013-12-27 |
EP2714687B1 (en) | 2017-02-15 |
AU2012264476B2 (en) | 2016-12-08 |
EP2714687A1 (en) | 2014-04-09 |
KR20140040766A (ko) | 2014-04-03 |
CA2837251A1 (en) | 2012-12-06 |
US9062049B2 (en) | 2015-06-23 |
AU2012264476A8 (en) | 2014-06-05 |
JP2014515392A (ja) | 2014-06-30 |
WO2012164242A1 (en) | 2012-12-06 |
US20140200228A1 (en) | 2014-07-17 |
AU2012264476A1 (en) | 2013-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX350892B (es) | Síntesis de compuesto antiviral. | |
NZ705827A (en) | Method of synthesizing thyroid hormone analogs and polymorphs thereof | |
MX2012004382A (es) | Procedimiento para la preparación de compuestos útiles como inhibidores del transportador de glucosa dependiente de sodio 2. | |
MX2020010330A (es) | Proceso para preparar un compuesto antiviral de formula i. | |
MX2016006336A (es) | Compuestos pirazolopirimidina. | |
NZ600119A (en) | Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives | |
NZ603268A (en) | Process for synthesizing oxidized lactam compounds | |
MX2013000295A (es) | Procedimiento de preparacion de un inhibidor especifico de la trombina. | |
MX2013011257A (es) | Proceso para la preparacion de dronedarona por n-butilacion. | |
MX2013000288A (es) | Metodo para fabricar quinolina-3-carboxamidas. | |
MX2013000773A (es) | Procedimiento de preparacion de derivados de amino-benzoil-benzofu rano. | |
MY167881A (en) | Process for preparing antiviral compounds | |
EP2590649A4 (en) | PROCESS FOR SYNTHESIS OF SUBSTITUTED MORPHINANES | |
IN2013MN02407A (ru) | ||
EP2665705A4 (en) | PROCESS FOR THE IMPROVED PREPARATION OF SUCCINIMIDE COMPLEXES OF MOLYBDENUM OF LOW MOLECULAR WEIGHT | |
IN2014DN00144A (ru) | ||
WO2012099736A3 (en) | Improved process for preparation of high molecular weight molybdenum succinimide complexes | |
MX2011009898A (es) | Proceso para la obtencion de derivados de acido propionico. | |
MX2012002818A (es) | Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable. | |
MX2013000294A (es) | Intermedios y procedimiento de preparación de un inhibidor específico de la trombina. | |
MX2010009926A (es) | Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico. | |
MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
WO2012026897A9 (en) | A process for the preparation of imatinib base | |
GB201104203D0 (en) | Chemical process | |
TN2014000329A1 (en) | Method for preparing compound by novel michael addition reaction using water or various acids as additive |